Cargando…

Correction: SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer

Detalles Bibliográficos
Autores principales:	Suresh, Shruthy, Durakoglugil, Deniz, Zhou, Xiaorong, Zhu, Bokai, Comerford, Sarah A., Xing, Chao, Xie, Xian-Jin, York, Brian, O’Donnell, Kathryn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894952/ https://www.ncbi.nlm.nih.gov/pubmed/29641518 http://dx.doi.org/10.1371/journal.pgen.1007344

Ejemplares similares

SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer
por: Suresh, Shruthy, et al.
Publicado: (2017)

Translational Control of Immune Evasion in Cancer
por: Suresh, Shruthy, et al.
Publicado: (2021)

SRC-2 Coactivator Deficiency Decreases Functional Reserve in Response to Pressure Overload of Mouse Heart
por: Reineke, Erin L., et al.
Publicado: (2012)

Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
por: Dasgupta, Subhamoy, et al.
Publicado: (2018)

Implications of the Estrogen Receptor Coactivators SRC1 and SRC2 in the Biological Basis of Gender Incongruence
por: Ramírez, Karla del Valle, et al.
Publicado: (2021)

SRC-3, a Steroid Receptor Coactivator: Implication in Cancer
por: Li, Licen, et al.
Publicado: (2021)

Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1
por: Choi, So Ra, et al.
Publicado: (2021)

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
Publicado: (2017)

Steroid receptor coactivator 3 (SRC-3/AIB1) is enriched and functional in mouse and human Tregs
por: Nikolai, Bryan C., et al.
Publicado: (2021)

SRC-2 Coactivator: a role in human metabolic evolution and disease
por: O’Malley, Bert W.
Publicado: (2020)

Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2)
por: Madsen, Andre, et al.
Publicado: (2015)

The Diarylheptanoid Curcumin Induces MYC Inhibition and Cross-Links This Oncoprotein to the Coactivator TRRAP
por: Mödlhammer, Alexander, et al.
Publicado: (2021)

SRC-3 Has a Role in Cancer Other Than as a Nuclear Receptor Coactivator
por: Ma, Gang, et al.
Publicado: (2011)

Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer
por: Wu, Meng-Jen, et al.
Publicado: (2021)

Correction: Sports-related concussion (SRC) in track cycling: SRC assessment protocol for elite track cycling
Publicado: (2022)

Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
por: Chen, Yu, et al.
Publicado: (2023)

Point Mutation of the neu Gene in Rat Neural Tumor RT4‐AC Cells: Suppression of Tumorigenicity by s‐Myc
por: Lee, Soo‐Yong, et al.
Publicado: (1990)

PFKFB4 promotes lung adenocarcinoma progression via phosphorylating and activating transcriptional coactivator SRC-2
por: Meng, Jiguang, et al.
Publicado: (2021)

Correction: Acceleration of the Glycolytic Flux by Steroid Receptor Coactivator-2 Is Essential for Endometrial Decidualization
por: Kommagani, Ramakrishna, et al.
Publicado: (2015)

Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation
por: Chang, Inik, et al.
Publicado: (2018)

Prostaglandins as Candidate Ligands for a Per-ARNT-Sim (PAS) Domain of Steroid Receptor Coactivator 1 (SRC1)
por: Daffern, Nicolas, et al.
Publicado: (2023)

Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2020)

Correction: Perturbing the Cellular Levels of Steroid Receptor Coactivator-2 Impairs Murine Endometrial Function
por: Szwarc, Maria M., et al.
Publicado: (2015)

Correction to: MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma
por: Cui, Li, et al.
Publicado: (2021)

Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
por: Perez, Marco, et al.
Publicado: (2016)

The Transcriptional Coactivators p/CIP and SRC-1 Control Insulin Resistance through IRS1 in Obesity Models
por: Wang, Zhiyong, et al.
Publicado: (2012)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Author Correction: Adapting the visuo-haptic perception through muscle coactivation
por: Carboni, Gerolamo, et al.
Publicado: (2022)

Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
por: Wang, Jie, et al.
Publicado: (2011)

Defining the mammalian coactivation of hepatic 12-h clock and lipid metabolism
por: Meng, Huan, et al.
Publicado: (2022)

Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression
por: Chen, Hsin-Yi, et al.
Publicado: (2022)

Correction: Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer
por: Ligr, Martin, et al.
Publicado: (2011)

Tumor Suppressor Role for the SPOP Ubiquitin Ligase in Signal-Dependent Proteolysis of the Oncogenic Coactivator SRC-3/AIB1
por: Li, Chao, et al.
Publicado: (2011)

Desmoglein 3 contributes to tumorigenicity of pancreatic ductal adenocarcinoma through activating Src–FAK signaling
por: Abula, Yimamumaimaitijiang, et al.
Publicado: (2021)

Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
por: Kim, Jongchan, et al.
Publicado: (2010)

Correction: IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
por: Chen, Miao-Fen, et al.
Publicado: (2016)

Correction: Agrin and Perlecan Mediate Tumorigenic Processes in Oral Squamous Cell Carcinoma
Publicado: (2015)

Correction: REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
Publicado: (2015)

Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas
por: Carrió, Meritxell, et al.
Publicado: (2019)

KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth
por: Shimoda, Michiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3bssoldevuiblc0k2lvvskhpg9